Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,056.80
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.83
(
-0.37%
)
Bitcoin
77,857.77
(
-0.54%
)
News Focus
News Focus
Post# of 236594
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Scooter McCabe

Send PM Follow Ignore
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Scooter McCabe

Re: Amatuer17 post# 85752

Saturday, 06/20/2020 11:03:55 AM

Saturday, June 20, 2020 11:03:55 AM

Post# of 236594
HIV market was 30 billion in 2019. Cancer is a 160 billion dollar market.
We expect 9 billion in revenue next year from COVID alone. HIV approval is pending as of October. 10 billion revenue would seem reasonable for mono and combo therapy.

So you have at least 19 billion in revenue coming, with cancer looking promising. So you have a nice profitable story stock company eating up market share with a CEO who won't sell out for less than "triple digits per share." Who isn't going to buy the ticket and take the ride?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CYDY News
More CYDY News